Novel reaction to new cystic fibrosis medication Trikafta

Abstract We present a novel case of an urticaria multiforme‐type drug reaction to the new cystic fibrosis medication Trikafta (elexacaftor + tezacaftor + ivacaftor). Equipped with this information, clinicians may be more prepared to counsel and treat patients if they experience similar symptoms afte...

Full description

Bibliographic Details
Main Authors:	Julian Stashower, Patrick Carr, Virginia Miller, Barrett Zlotoff
Format:	Article
Language:	English
Published:	Wiley 2021-05-01
Series:	Clinical Case Reports
Subjects:	cystic fibrosis drug rash Trikafta urticaria urticaria multiforme
Online Access:	https://doi.org/10.1002/ccr3.4116

id	doaj-d61cf6719f3e4eee9ac4c78e8c3b5c1c
record_format	Article
spelling	doaj-d61cf6719f3e4eee9ac4c78e8c3b5c1c2021-06-04T10:35:48ZengWileyClinical Case Reports2050-09042021-05-0195n/an/a10.1002/ccr3.4116Novel reaction to new cystic fibrosis medication TrikaftaJulian Stashower0Patrick Carr1Virginia Miller2Barrett Zlotoff3University of Virginia School of Medicine Charlottesville VA USADepartment of Dermatology University of Virginia School of Medicine Charlottesville VA USADepartment of Pathology University of Virginia School of Medicine Charlottesville VA USADepartments of Dermatology and Pediatrics Pediatric Dermatology University of Virginia School of Medicine Charlottesville VA USAAbstract We present a novel case of an urticaria multiforme‐type drug reaction to the new cystic fibrosis medication Trikafta (elexacaftor + tezacaftor + ivacaftor). Equipped with this information, clinicians may be more prepared to counsel and treat patients if they experience similar symptoms after beginning Trikafta.https://doi.org/10.1002/ccr3.4116cystic fibrosisdrug rashTrikaftaurticariaurticaria multiforme
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Julian Stashower Patrick Carr Virginia Miller Barrett Zlotoff
spellingShingle	Julian Stashower Patrick Carr Virginia Miller Barrett Zlotoff Novel reaction to new cystic fibrosis medication Trikafta Clinical Case Reports cystic fibrosis drug rash Trikafta urticaria urticaria multiforme
author_facet	Julian Stashower Patrick Carr Virginia Miller Barrett Zlotoff
author_sort	Julian Stashower
title	Novel reaction to new cystic fibrosis medication Trikafta
title_short	Novel reaction to new cystic fibrosis medication Trikafta
title_full	Novel reaction to new cystic fibrosis medication Trikafta
title_fullStr	Novel reaction to new cystic fibrosis medication Trikafta
title_full_unstemmed	Novel reaction to new cystic fibrosis medication Trikafta
title_sort	novel reaction to new cystic fibrosis medication trikafta
publisher	Wiley
series	Clinical Case Reports
issn	2050-0904
publishDate	2021-05-01
description	Abstract We present a novel case of an urticaria multiforme‐type drug reaction to the new cystic fibrosis medication Trikafta (elexacaftor + tezacaftor + ivacaftor). Equipped with this information, clinicians may be more prepared to counsel and treat patients if they experience similar symptoms after beginning Trikafta.
topic	cystic fibrosis drug rash Trikafta urticaria urticaria multiforme
url	https://doi.org/10.1002/ccr3.4116
work_keys_str_mv	AT julianstashower novelreactiontonewcysticfibrosismedicationtrikafta AT patrickcarr novelreactiontonewcysticfibrosismedicationtrikafta AT virginiamiller novelreactiontonewcysticfibrosismedicationtrikafta AT barrettzlotoff novelreactiontonewcysticfibrosismedicationtrikafta
_version_	1721397638573588480

Novel reaction to new cystic fibrosis medication Trikafta

Similar Items